RenovoRx, Inc.
RNXTNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $61.01M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.70$2.59
- Volume (live)
- -
- Avg. volume (3M)
- 529.75K
RenovoRx (RNXT) Stock Price & Financial Analysis
RenovoRx Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.25 - $1.31 |
|---|---|
| 52-Week High | $2.59 |
| 52-Week Low | $0.70 |
| Open | $1.25 |
| Volume (last close) | 284.14K |
| Average Volume (3M) | 529.75K |
| Revenue (TTM) | 1.98M |
|---|---|
| Net Income (TTM) | -12.29M |
| Free Cash Flow (TTM) | -11.94M |
| EPS (TTM) | −$0.31 |
| Profit Margin | -621.71% |
| Operating Margin | -685.27% |
| Return on Equity (ROE) | -136.82% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 61.01M |
|---|---|
| Shares Outstanding | 47.30M |
| Price to Sales (P/S) | 30.88 |
| Price to Book (P/B) | 6.80 |
| EV/EBITDA | -3.76 |
| 50-Day MA | $1.54 |
|---|---|
| 200-Day MA | $1.09 |
| 1-Year Change | +10.43% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
RenovoRx at a Glance
As of the Oct 23, 2026 close, RenovoRx (RNXT) has a market capitalization of $61.01M. The stock trades at 30.9× sales. Over the trailing twelve months it lost $12.29M on revenue of $1.98M and burned $11.94M of free cash flow. Revenue grew 180.3% year over year.
As of its latest reported balance sheet, it holds $9.48M in cash and securities against $259.00K of debt, a net cash position of $9.22M.
RenovoRx does not currently pay a dividend.
The share price is up 10.4% over the past year. At $1.29 (the Oct 23, 2026 close) it sits within its 52-week range of $0.70 to $2.59, above its 200-day moving average of $1.09.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About RenovoRx
What is the current stock price for RNXT?
As of the Oct 23, 2026 close, RNXT stock trades at $1.29. The 52-week range is $0.70–$2.59, with a day range of $1.25–$1.31.
What is the P/E ratio for RNXT?
The P/E ratio (Price-to-Earnings) for RNXT is shown in the Key Statistics section. This valuation metric helps compare RenovoRx, Inc. to industry peers.
Does RNXT pay dividends?
RenovoRx does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RNXT?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for RNXT is Hold.
What is the market cap of RNXT?
As of the Oct 23, 2026 close, RenovoRx's market capitalization is $61.0M, classifying it as a micro-cap company. RenovoRx operates in the Healthcare sector within the Biotechnology industry.